When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Rigel Pharmaceuticals' (RIGL) Tavalisse, launched in mid-2018, is experiencing sales growth but competitors exist that could potentially reduce peak sales. RIGL's partnered pipeline provides a source of potentially good news to offset any bad news regarding advances from RIGL's competitors. These competitors and collaborators are the focus of this article.
Figure 1: Numbers on the launch of Tavalisse. Source: RIGL corporate presentation.
Aclaris' ATI-501 and ATI-502
Aclaris Therapeutics (ACRS) is developing ATI-501 and ATI-502, which the company licensed from RIGL. Since I previously wrote about ATI-501 and ATI-502, ACRS has